Skip to main content

News

COVID-19
By Charles Alessi | 02:34 am | April 20, 2020
In this COVID-19 era, the need for health and care systems to become agile and change is very real. 
By Sophie Porter | 03:14 am | April 18, 2020
The new, shared online appointment and prescribing platform is intended to relieve NHS pressure.
By Jonah Comstock | 05:38 pm | April 17, 2020
Seven witnesses submitted statements and answered questions, leaving Senators with promising tech ideas, legislative priorities and words of caution.
By Dave Muoio | 03:30 pm | April 17, 2020
The COVID-19 Telehealth Program and the Connected Care Pilot Program together are set to invest $300 million so that healthcare providers can reach the patients in greatest need of virtual-care services. 
By Tammy Lovell | 02:12 pm | April 17, 2020
The technology by Deputy offers a “touchless clock-in” for staff which enables them to register for work without touching a screen.  
By Tammy Lovell | 01:42 pm | April 17, 2020
The guidance on how to identify and manage symptoms will be provided to all UK GP surgeries. 
By Laura Lovett | 05:14 pm | April 16, 2020
The new tool will be combined with Biofourmis' Biovitals platform and be able to give insights to cancer patients at home. 
By Dave Muoio | 05:10 pm | April 16, 2020
Also: Mercom's Q1 2020 digital health funding report; Fitbit, Scripps, Stanford collaborate on COVID-19 detection research.
03:51 pm | April 16, 2020
Just as it's doing with nearly every facet of society around the world, the COVID-19 crisis will radically transform approaches with patient engagement and pop health. From telemedicine and remote patient monitoring to AI and advanced analytics, healthcare was already in the midst of big changes in how it manages the health of patient populations. Now, in a new era where the pandemic is upending old assumptions, the stakes are even higher. This month, we look at how approaches to treating COVID-19 and other illnesses are shifting in this new era.  
By Dave Muoio | 03:38 pm | April 16, 2020
A new guidance from the U.S. regulator relaxes a handful of requirements for these digital health devices, and clarifies the agency's long-term enforcement policy for low-risk wellness products.